DCM
DXCM icon

Dupont Capital Management’s DexCom DXCM Stock Holding History

Dupont Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,964
Closed -$638K – 327
2023
Q2 		$638K Buy
4,964
+2,407
+94% +$291K 0.03% 237
2023
Q1 		$297K Sell
2,557
-10,881
-81% -$1.22M 0.01% 413
2022
Q4 		$1.52M Buy
13,438
+677
+5% +$74.3K 0.07% 214
2022
Q3 		$1.03M Buy
12,761
+1,985
+18% +$168K 0.06% 341
2022
Q2 		$803K Hold
10,776
– – 0.04% 551
2022
Q1 		$1.38M Buy
10,776
+6,124
+132% +$670K 0.06% 369
2021
Q4 		$624K Sell
4,652
-8,044
-63% -$1.16M 0.02% 715
2021
Q3 		$1.74M Buy
12,696
+6,240
+97% +$787K 0.05% 364
2021
Q2 		$689K Buy
+6,456
New +$620K 0.02% 810
2020
Q4 		– Sell
-23,776
Closed -$2.45M – 1327
2020
Q3 		$2.45M Sell
23,776
-6,860
-22% -$717K 0.05% 262
2020
Q2 		$3.1M Buy
30,636
+13,056
+74% +$1.17M 0.07% 219
2020
Q1 		$1.18M Sell
17,580
-5,032
-22% -$313K 0.03% 410
2019
Q4 		$1.24M Buy
22,612
+7,384
+48% +$350K 0.03% 501
2019
Q3 		$568K Buy
15,228
+4,380
+40% +$170K 0.01% 723
2019
Q2 		$406K Sell
10,848
-4,376
-29% -$138K 0.01% 875
2019
Q1 		$453K Buy
+15,224
New +$535K 0.01% 793
2018
Q1 		– Sell
-29,000
Closed -$416K – 965
2017
Q4 		$416K Sell
29,000
-5,648
-16% -$73.4K 0.01% 701
2017
Q3 		$424K Buy
34,648
+6,240
+22% +$110K 0.01% 708
2017
Q2 		$520K Buy
28,408
+15,684
+123% +$290K 0.01% 677
2017
Q1 		$270K Buy
+12,724
New +$248K 0.01% 793
2015
Q3 		– Sell
-94,200
Closed -$1.88M – 605
2015
Q2 		$1.88M Buy
+94,200
New +$1.65M 0.04% 354

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dupont Capital Management's DXCM Position: Q3 2023 in Review

Dupont Capital Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 4,964 shares — an estimated $638K sold.

Dupont Capital Management first reported a position in DXCM in Q2 2015 and held it in 21 quarters. The position peaked at $3.1M in Q2 2020. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Dupont Capital Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Dupont Capital Management sold 4,964 DexCom shares in Q3 2023, an estimated $638K.
  • Dupont Capital Management first reported a position in DexCom in Q2 2015 and held it in 21 quarters.
  • Dupont Capital Management's DexCom position peaked at $3.1M in Q2 2020.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Dupont Capital Management's 13F filing for Q3 2023, filed 27 Oct 2023.